Cargando…
Value of CD44 immunostaining (IHC) as a surrogate in the differentiation of MYC-positive Burkitt lymphoma (BL) and Burkitt lymphoma-like (BLL) from MYC-negative Diffuse Large B-Cell Lymphoma (DLBCL) in a resource constrained clinical setting
Autores principales: | Ayers, LW, Ogwang, M, Zhou, W, Mbulaiteye, SM, Bhatia, K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261845/ http://dx.doi.org/10.1186/1750-9378-4-S2-P6 |
Ejemplares similares
-
Burkitt Lymphoma: beyond discoveries
por: Mbulaiteye, Sam M
Publicado: (2013) -
Burkitt lymphoma beyond MYC translocation: N-MYC and DNA methyltransferases dysregulation
por: De Falco, Giulia, et al.
Publicado: (2015) -
Deep Sequencing of MYC DNA-Binding Sites in Burkitt Lymphoma
por: Seitz, Volkhard, et al.
Publicado: (2011) -
Alteration of MicroRNAs Regulated by c-Myc in Burkitt Lymphoma
por: Onnis, Anna, et al.
Publicado: (2010) -
Developments in Burkitt’s lymphoma: novel cooperations in oncogenic MYC signaling
por: Spender, Lindsay C, et al.
Publicado: (2014)